Imdaptive is a proof-of-concept stage biotechnology company with facilities located in the greater Seattle area. Imdaptive is focused on developing new methods for profiling changes in the adaptive immune system over time. These new techniques have implications in disease profiling, creation of therapeutic entities, and personalized medicine.
Imdaptive is currently seeking partnerships in both the industrial and academic communities to demonstrate the use of our technology for therapeutic creation and diagnostics. Please contact us in order to arrange a confidential presentation.